Get the Stockscreener App
236.83
1.01%
-2.42
After Hours:
236.83
Overview
News
Price History
Option Chain
Financials
Why LH Down?
Discussions
Forecast
Stock Split
Dividend History
Labcorp Holdings Inc stock is traded at $236.83, with a volume of 935.02K.
It is down -1.01% in the last 24 hours and down -1.79% over the past month.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
See More
Previous Close:
$239.25
Open:
$238.29
24h Volume:
935.02K
Relative Volume:
1.71
Market Cap:
$19.82B
Revenue:
$12.71B
Net Income/Loss:
$435.50M
P/E Ratio:
45.99
EPS:
5.15
Net Cash Flow:
$843.20M
1W Performance:
-6.87%
1M Performance:
-1.79%
6M Performance:
+7.62%
1Y Performance:
+9.21%
1-Day Range:
$230.97
$239.76
1-Week Range:
$230.97
$256.13
52-Week Range:
$191.97
$258.59
Labcorp Holdings Inc Stock (LH) Company Profile
Name
Labcorp Holdings Inc
Sector
Industry
Phone
(336) 229-1127
Address
358 S MAIN ST, BURLINGTON, NC
Compare LH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
236.83 | 19.82B | 12.71B | 435.50M | 843.20M | 5.15 |
|
TMO
Thermo Fisher Scientific Inc
|
512.65 | 193.40B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
204.96 | 146.49B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
119.85 | 34.19B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IDXX
Idexx Laboratories Inc
|
412.40 | 33.54B | 3.90B | 887.87M | 798.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
185.42 | 32.69B | 15.41B | 1.37B | 2.11B | 7.50 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
| Jan-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-10-24 | Resumed | Jefferies | Buy |
| Oct-30-24 | Upgrade | HSBC Securities | Hold → Buy |
| Oct-01-24 | Initiated | Piper Sandler | Neutral |
| Mar-25-24 | Upgrade | Argus | Hold → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-09-24 | Initiated | Evercore ISI | In-line |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-19-22 | Downgrade | Argus | Buy → Hold |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-11-21 | Upgrade | Argus | Hold → Buy |
| Jan-11-21 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Jan-08-21 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-13-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-02-20 | Resumed | Deutsche Bank | Buy |
| May-15-20 | Upgrade | Mizuho | Neutral → Buy |
| Apr-29-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
| Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jul-16-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jun-21-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
| Jan-17-19 | Initiated | UBS | Buy |
| Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Dec-03-18 | Downgrade | Craig Hallum | Buy → Hold |
| Oct-30-18 | Downgrade | Argus | Buy → Hold |
| Oct-25-18 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-19-18 | Resumed | BofA/Merrill | Buy |
| Jun-07-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| May-01-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-23-18 | Initiated | Argus | Buy |
View All
Labcorp Holdings Inc Stock (LH) Latest News
Labcorp Warns Fed. Circ. Of 'Balkanization' In Prenatal IP Row - Law360
Labcorp’s SWOT analysis: clinical testing giant’s stock faces growth opportunities - Investing.com
Labcorp to acquire certain assets of Opko Health’s BioReference Health - Yahoo Finance
Truist remains bullish on Labcorp after ‘another nice strategic acquisition’ - Yahoo Finance
Labcorp to buy Opko unit’s cancer test assets for up to $225M - Yahoo Finance
Labcorp to acquire BioReference Health assets for up to $225M By Investing.com - Investing.com Canada
Opko Health Sells BioReference Assets to Labcorp - TipRanks
Labcorp Announces Acquisition Of Select Assets Of Bioreference Health's Innovative Oncology And Related Clinical Testing Services Businesses - Marketscreener.com
Labcorp to buy certain assets of OPKO unit BioReference Health - MSN
Labcorp stock gains on deal to buy OPKO assets (LH:NYSE) - Seeking Alpha
Labcorp to Buy Some OPKO BioReference Assets for Up to $225 Million - MarketWatch
Labcorp To Buy Certain Assets Of BioReference Health For A Maximum $225 Mln - Nasdaq
Labcorp's $225M Oncology Testing Expansion: Strategic BioReference Assets Acquisition Promises Market Growth - StockTitan
Labcorp Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
Labcorp Holdings' (NYSE:LH) Strong Earnings Are Of Good Quality - Yahoo Finance
Charles River, LabCorp upgraded, Quest downgraded at Citi on valuation - MSN
Labcorp director Anderson sells shares for $127,817 By Investing.com - Investing.com South Africa
Labcorp director Anderson sells shares for $127,817 - Investing.com
Should Labcorp Stock Stay In Your Portfolio Right Now? - Barchart
Should Labcorp Stock Stay in Your Portfolio Right Now? - Yahoo Finance
Labcorp Faces Mixed Investor Reactions Amid Market FluctuationsNews and Statistics - IndexBox, Inc.
Citigroup Upgrades Labcorp Holdings (LH) - MSN
Labcorp Gains Citi Upgrade While Quest Diagnostics Faces Downgrade On Margin Concerns — Retail Sentiment Mixed - MSN
Labcorp’s EVP Mark Schroeder sells $1.33 million in stock By Investing.com - Investing.com South Africa
Labcorp’s EVP Mark Schroeder sells $1.33 million in stock - Investing.com India
What 10 Analyst Ratings Have To Say About Labcorp Hldgs - Benzinga
Citigroup Upgrades Labcorp Holdings to Buy From Neutral, Adjusts Price Target to $300 From $250 - Marketscreener.com
Fortrea Faces Spin-Related Challenges in the Near Term; Positive Long-Term Outlook - Morningstar
Labcorp Holdings Insider Sold Shares Worth $1,330,639, According to a Recent SEC Filing - Marketscreener.com
Is the Market Bullish or Bearish on Labcorp Hldgs? - Benzinga
Labcorp Expects Major Revenue Growth Thanks To Rising Test Demand - Finimize
Insider Sell: van der Vaart Sandra D Sells 1,314 Shares of Labco - GuruFocus.com
Labcorp Executive Cashes In on Stock Sale! - TipRanks
Labcorp Holdings EVP sells $330,208 in stock By Investing.com - Investing.com Australia
Labcorp Holdings EVP sells $330,208 in stock - Investing.com India
LabCorp Holdings EVP Sells Shares - TradingView
Insider Sell: Amy Summy Sells Shares of Labcorp Holdings Inc (LH) - GuruFocus.com
LabCorp EVP Amy Summy sells $56,590 in common stock By Investing.com - Investing.com South Africa
Are Wall Street Analysts Predicting Labcorp Holdings Stock Will Climb or Sink? - MSN
LabCorp EVP Amy Summy sells $56,590 in common stock - Investing.com India
Here's Why Labcorp (LH) is a Strong Value Stock - Nasdaq
Ex-Dividend Reminder: Molson Coors Beverage, Marriott International and Labcorp Holdings - Nasdaq
Labcorp Holdings (NYSE:LH) Will Pay A Dividend Of $0.72 - Yahoo Finance
Labcorp releases liquid biopsy for advanced cancer care By Investing.com - Investing.com South Africa
Labcorp Makes DNA-Based Cancer Test Available -February 24, 2025 at 08:18 am EST - Marketscreener.com
Can a Simple Blood Draw Replace Tumor Biopsies? Labcorp's New Cancer Test Changes the Game - StockTitan
Labcorp Announces Clinical Availability of Liquid Biopsy Test to Guide Personalized Treatment Plans for Patients with Advanced Solid Tumors - PR Newswire
Here's What We Like About Labcorp Holdings' (NYSE:LH) Upcoming Dividend - Yahoo Finance
Labcorp Holdings Inc Stock (LH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.03%
3.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):